Cell signaling is the fundamental process by which cells communicate with their environment and each other to coordinate growth, metabolism, differentiation, and apoptosis. Signal transduction converts extracellular signals into intracellular responses through a series of molecular events.
Types of Cell Signaling
Endocrine signaling involves hormones secreted into the bloodstream that act on distant target cells — examples include insulin, thyroid hormone, and cortisol. Paracrine signaling involves signaling molecules acting on nearby cells, such as neurotransmitters at synapses, growth factors in tissue development, and inflammatory cytokines. In autocrine signaling, a cell responds to signals it produces itself, which is common in immune responses and cancer cells that produce their own growth factors. Juxtacrine signaling involves direct cell-cell contact via membrane-bound ligands and receptors (e.g., Notch-Delta signaling and integrin-mediated adhesion). Contact-dependent signaling through gap junctions allows direct passage of small signaling molecules (cAMP, IP₃, ions) between adjacent cells.
Signal Molecules and Receptors
Signaling molecules (ligands) include proteins (growth factors, cytokines, hormones), peptides, amino acid derivatives (epinephrine, thyroxine), steroids (estrogen, testosterone), gases (NO, CO), and lipids (prostaglandins). Receptor types include G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTKs), ion channel-coupled receptors, and intracellular receptors (nuclear hormone receptors). Receptor-ligand binding is specific, reversible, and characterized by affinity (Kd); binding induces conformational changes that initiate intracellular signaling.
G Protein-Coupled Receptors (GPCRs)
GPCRs are seven-transmembrane domain receptors coupled to heterotrimeric G proteins (alpha, beta, gamma subunits) and represent the largest receptor family with over 800 members. Ligand binding activates the G protein: GDP is exchanged for GTP on the alpha subunit, which dissociates from beta-gamma and modulates effector enzymes. Major effectors include adenylyl cyclase (cAMP production), phospholipase C (IP₃ and DAG production), and ion channels. Second messengers include cAMP (activates PKA), IP₃ (releases Ca²⁺ from ER), DAG (activates PKC), and Ca²⁺ (activates calmodulin and CaM kinases). Signal termination occurs through GTP hydrolysis by the alpha subunit (GTPase), receptor desensitization by GRK-mediated phosphorylation and beta-arrestin binding, and cAMP degradation by phosphodiesterases.
Receptor Tyrosine Kinases (RTKs)
RTKs are single-pass transmembrane receptors with intrinsic tyrosine kinase activity — examples include the insulin receptor, EGF receptor, PDGF receptor, and VEGF receptor. Ligand binding induces receptor dimerization and autophosphorylation of tyrosine residues in the cytoplasmic domain. Phosphorylated tyrosines serve as docking sites for SH2 domain-containing proteins, including Ras-GEF (SOS), PI3K, and PLC-γ. The Ras-MAPK cascade involves SOS activating Ras (a GTPase), which recruits Raf (MAPKKK), which phosphorylates MEK (MAPKK), which phosphorylates ERK (MAPK), ultimately regulating transcription factors such as Elk-1, c-Myc, and c-Fos. The PI3K-Akt pathway involves PI3K generating PIP₃, which recruits PDK1 and Akt; Akt promotes cell survival (inhibits Bad, Caspase-9), metabolism (activates mTOR), and growth.
Intracellular Receptors
Nuclear hormone receptors are ligand-activated transcription factors that include steroid hormone receptors (glucocorticoid, estrogen, progesterone, androgen) and the thyroid hormone receptor. Lipophilic hormones cross the plasma membrane and bind cytoplasmic or nuclear receptors, inducing conformational changes that expose DNA-binding domains. The receptor-hormone complex then translocates to the nucleus, binds hormone response elements (HREs) in DNA, and recruits co-activators or co-repressors to regulate transcription.
Ion Channel-Coupled Receptors
The nicotinic acetylcholine receptor is a ligand-gated ion channel that opens upon acetylcholine binding, allowing Na⁺ influx and membrane depolarization in neuromuscular junctions. The GABA-A receptor is a ligand-gated Cl⁻ channel and the major inhibitory neurotransmitter receptor, serving as a target for benzodiazepines and barbiturates. Ion channels mediate rapid synaptic transmission (milliseconds), in contrast to GPCR and RTK signaling (seconds to minutes).
Signal Amplification and Integration
Signal amplification occurs at multiple levels: a single ligand-receptor complex can activate many G proteins, each adenylyl cyclase generates many cAMP molecules, and each PKA phosphorylates many target proteins. Signal integration reflects the fact that cells receive multiple signals simultaneously, and the integrated response depends on the balance of activating and inhibitory pathways (e.g., insulin vs. glucagon, growth factors vs. tumor suppressors). Cross-talk between different signaling pathways is common — for example, PKA can phosphorylate and inhibit Raf, linking GPCR and RTK signaling. Scaffold proteins organize signaling components into complexes, increasing efficiency and specificity (e.g., KSR scaffolds Raf-MEK-ERK).
Dysregulation in Disease
Constitutive activation of RTKs — such as mutant EGFR in lung cancer and HER2 amplification in breast cancer — drives uncontrolled proliferation. GPCR mutations can cause constitutive activation of the TSH receptor in hyperthyroidism or loss-of-function of rhodopsin in retinitis pigmentosa. Ras mutations (G12V, G13D) lock Ras in the GTP-bound active state and are found in 30% of human cancers (pancreatic, colorectal, lung). PI3K-Akt pathway hyperactivation is common in cancer through PTEN loss, PIK3CA mutations, or Akt amplification.
